Inflammatory myofibroblastic tumor with ALK/TPM3 fusion presenting as ileocolic intussusception : an unusual presentation of an unusual neoplasmMILNE, Anya N. A; SWEENEY, Karl J; O'RIORDAIN, Diarmuid S et al.Human pathology. 2006, Vol 37, Num 1, pp 112-116, issn 0046-8177, 5 p.Article

Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: Role of the co-chaperone carboxyl heat shock protein 70-interacting proteinBONVINI, Paolo; DALLA ROSA, Henry; VIGNES, Nadia et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3256-3264, issn 0008-5472, 9 p.Article

Anaplastic large cell lymphoma : A flow cytometric analysis of 29 casesKESLER, Melissa V; PARANJAPE, Geeta S; ASPLUND, Sheryl L et al.American journal of clinical pathology. 2007, Vol 128, Num 2, pp 314-322, issn 0002-9173, 9 p.Article

ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK InhibitorsHEUCKMANN, Johannes M; HÖLZEL, Michael; RAUH, Daniel et al.Clinical cancer research (Print). 2011, Vol 17, Num 23, pp 7394-7401, issn 1078-0432, 8 p.Article

Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic TumorBUTRYNSKI, James E; D'ADAMO, David R; KWAK, Eunice L et al.The New England journal of medicine. 2010, Vol 363, Num 18, pp 1727-1733, issn 0028-4793, 7 p.Article

Anaplastic Lymphoma Kinase (ALK)-Induced Malignancies: Novel Mechanisms of Cell Transformation and Potential Therapeutic ApproachesWASIK, Mariusz A; QIAN ZHANG; MARZEC, Michal et al.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, S27-S35, SUP1Article

Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumorXIAOKE WANG; KRISHNAN, Chandra; OLIVEIRA, Andre M et al.Human pathology. 2012, Vol 43, Num 11, pp 2047-2052, issn 0046-8177, 6 p.Article

Inflammatory Myofibroblastic Tumors in Childhood: A Report From the Italian Cooperative Group StudiesALAGGIO, Rita; CECCHETTO, Giovanni; BISOGNO, Gianni et al.Cancer. 2010, Vol 116, Num 1, pp 216-226, issn 0008-543X, 11 p.Article

Pediatric inflammatory myofibroblastic tumor : Anaplastic lymphoma kinase (ALK) expression and prognosisCHUN, Yun S; LINAN WANG; NASCIMENTO, Antonio G et al.Pediatric blood & cancer. 2005, Vol 45, Num 6, pp 796-801, issn 1545-5009, 6 p.Article

The Expression of Myeloid Antigens CD13 and/or CD33 Is a Marker of ALK+ Anaplastic Large Cell LymphomasBOVIO, Ian M; ALLAN, Robert W.American journal of clinical pathology. 2008, Vol 130, Num 4, pp 628-634, issn 0002-9173, 7 p.Article

Anaplastic large cell lymphoma : EAHPMEDEIROS, L. Jeffrey; ELENITOBA-JOHNSON, Kojo S. J.American journal of clinical pathology. 2007, Vol 127, Num 5, pp 707-722, issn 0002-9173, 16 p.Article

ALK^-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK⁺ ALCL and peripheral T-cell lymphoma, not otherwise specified : report from the International Peripheral T-Cell Lymphoma ProjectSAVAGE, Kerry J; LEE HARRIS, Nancy; ARMITAGE, James O et al.Blood. 2008, Vol 111, Num 12, pp 5496-5504, issn 0006-4971, 9 p.Article

Anaplastic Lymphoma Kinase-Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor PrognosisLAURENT, Camille; DO, Catherine; GASCOYNE, Randy D et al.Journal of clinical oncology. 2009, Vol 27, Num 25, pp 4211-4216, issn 0732-183X, 6 p.Article

Inhibition of ALK Signaling for Cancer TherapyMOSSE, Yael P; WOOD, Andrew; MARIS, John M et al.Clinical cancer research (Print). 2009, Vol 15, Num 18, pp 5609-5614, issn 1078-0432, 6 p.Article

Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphomaLAI, Raymond; RASSIDAKIS, George Z; MEDEIROS, L. Jeffrey et al.The American journal of pathology. 2004, Vol 164, Num 6, pp 2251-2258, issn 0002-9440, 8 p.Article

Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion VariantsHEUCKMANN, Johannes M; BALKE-WANT, Hyatt; KÜPPERS, Ralf et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4682-4690, issn 1078-0432, 9 p.Article

The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated junB level in a cell type-specific mannerHSU, Faye Yuan-Yi; JOHNSTON, Patrick B; BURKE, Kathleen A et al.Cancer research (Baltimore). 2006, Vol 66, Num 18, pp 9002-9008, issn 0008-5472, 7 p.Article

Biological role of anaplastic lymphoma kinase in neuroblastomaOSAJIMA-HAKOMORI, Yuko; MIYAKE, Izumi; OHIRA, Miki et al.The American journal of pathology. 2005, Vol 167, Num 1, pp 213-222, issn 0002-9440, 10 p.Article

MicroRNA 96 Is a Post-Transcriptional Suppressor of Anaplastic Lymphoma Kinase ExpressionVISHWAMITRA, Deeksha; YONG LI; AMIN, Hesham M et al.The American journal of pathology. 2012, Vol 180, Num 5, pp 1772-1780, issn 0002-9440, 9 p.Article

A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase InhibitorsSASAKI, Takaaki; KOIVUNEN, Jussi; CAPELLETTI, Marzia et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 18, pp 6051-6060, issn 0008-5472, 10 p.Article

Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK GeneAVANIYAPURAM KANNAN MURUGAN; MINGZHAO XING.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 13, pp 4403-4411, issn 0008-5472, 9 p.Article

Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase InhibitorsLOVLY, Christine M; HEUCKMANN, Johannes M; DE STANCHINA, Elisa et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 14, pp 4920-4931, issn 0008-5472, 12 p.Article

Oncogenic mutations of ALK in neuroblastomaOGAWA, Seishi; TAKITA, Junko; SANADA, Masashi et al.Cancer science. 2011, Vol 102, Num 2, pp 302-308, issn 1347-9032, 7 p.Article

Cell Culture Modeling of Genotype-Directed Sensitivity to Selective Kinase Inhibitors: Targeting the Anaplastic Lymphoma Kinase (ALK)SETTLEMAN, Jeff.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, S36-S41, SUP1Article

ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLCCASALUCE, Francesca; SGAMBATO, Assunta; MAIONE, Paolo et al.Targeted oncology. 2013, Vol 8, Num 1, pp 55-67, issn 1776-2596, 13 p.Article